Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Acute Ulcerative Colitis
NCT00385736
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
576
Enrollment
INDUSTRY
Sponsor class
Conditions
Ulcerative Colitis
Interventions
BIOLOGICAL:
adalimumab
BIOLOGICAL:
adalimumab
BIOLOGICAL:
placebo
Sponsor
Abbott